Perrigo (PRGO) Intangibles (2013 - 2026)
Perrigo's (PRGO) quarterly Intangibles came in at $2.3 billion in Q1 2026, down 8.04% year-on-year from $2.5 billion in Q1 2025, and down 3.92% on a QoQ basis from $2.4 billion in Q4 2025.
Perrigo (PRGO) Intangibles (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Intangibles data on file, last reported at $2.3 billion in Q1 2026.
- On a quarterly basis, Intangibles fell 8.04% year-over-year to $2.3 billion in Q1 2026; TTM through Mar 2026 was $2.3 billion, a 8.04% decrease from a year earlier, with the FY2025 full-year figure at $2.4 billion, down 2.98% from the prior year.
- Intangibles for Q1 2026 stood at $2.3 billion, down from $2.4 billion in the prior quarter.
- Over the last five years, Intangibles for PRGO reached as high as $3.2 billion in Q4 2022 and fell as low as $2.1 billion in Q2 2022.
- Historically, Intangibles has averaged $2.7 billion across 5 years, with a median of $2.7 billion in 2024.
- Across the five-year window, Intangibles surged 50.51% in 2022 and fell 18.69% in 2024, its largest moves.
- Year by year, Intangibles stood at $3.2 billion in 2022, then dropped by 7.72% to $3.0 billion in 2023, then decreased by 18.69% to $2.4 billion in 2024, then dropped by 2.98% to $2.4 billion in 2025, then decreased by 3.92% to $2.3 billion in 2026.
- Per Business Quant data, the three most recent Intangibles figures were $2.3 billion in Q1 2026, $2.4 billion in Q4 2025, and $2.4 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn | 2.26 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 2.26 Bn |
| Dec 31, 2025 | 2.35 Bn |
| Sep 27, 2025 | 2.40 Bn |
| Jun 28, 2025 | 2.56 Bn |
| Mar 29, 2025 | 2.46 Bn |
| Dec 31, 2024 | 2.42 Bn |
| Sep 28, 2024 | 2.66 Bn |
| Jun 29, 2024 | 2.63 Bn |
| Mar 30, 2024 | 2.87 Bn |
| Dec 31, 2023 | 2.98 Bn |
| Sep 30, 2023 | 2.94 Bn |
| Jul 1, 2023 | 3.03 Bn |
| Apr 1, 2023 | 3.08 Bn |
| Dec 31, 2022 | 3.23 Bn |
| Oct 1, 2022 | 3.00 Bn |
| Jul 2, 2022 | 3.22 Bn |
| Apr 2, 2022 | 2.05 Bn |
| Dec 31, 2021 | 2.15 Bn |
| Oct 2, 2021 | 2.23 Bn |
| Jul 3, 2021 | 2.31 Bn |